Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.21
-0.0150-1.23%
Volume:10.27K
Turnover:12.49K
Market Cap:60.03M
PE:-1.08
High:1.29
Open:1.29
Low:1.19
Close:1.22
Loading ...
Jan 14, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jan 10, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jan 10, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jan 10, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 04, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 28, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2024

Major Issues Report

Form 8-K - Current report
Mar 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities